Diana Patricia Portales-Pérez

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineCheminformatics and quantitative structure-activity relationshipsNoise and wave pollution processes and measurement
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 09, 2026
Profiles of microRNAs in Patients with Advanced Breast Cancer Who are Chemoresistant or Chemosensitive to Fluorouracil, Adriamycin, and Cyclophosphamide Treatment.

Eneida Turiján-Espinoza, Victor Manuel Ruíz-Rodríguez, Victor Alejandro Paz-Rodríguez

|Apr 25, 2024
miR-21, miR-221, miR-29 and miR-34 are distinguishable molecular features of a metabolically unhealthy phenotype in young adults.

Alejandro Méndez-Mancilla, Eneida Turiján-Espinoza, Mariela Vega-Cárdenas

|Aug 26, 2023
Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-fluoroquinolone in In Vitro, In Silico, and In Vivo Models.

Mitzzy Fátima Medellín-Luna, Hiram Hernández-López, Julio Enrique Castañeda-Delgado

|Jan 20, 2023
Differential Expression of AhR in Peripheral Mononuclear Cells in Response to Exposure to Polycyclic Aromatic Hydrocarbons in Mexican Women.

José Antonio Varela-Silva, Miguel Ernesto Martínez-Leija, Sandra Teresa Orta-García

|Mar 19, 2021
Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.

Eneida Turiján-Espinoza, Víctor Manuel Ruíz-Rodríguez, Edith Elena Uresti-Rivera

Pageof 1